Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control

Research output: Contribution to journalReview article

Standard

Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control. / Massoumi, Ramin; Paus, Ralf.

In: BioEssays, Vol. 29, No. 12, 2007, p. 1203-1214.

Research output: Contribution to journalReview article

Harvard

APA

CBE

MLA

Vancouver

Author

RIS

TY - JOUR

T1 - Cylindromatosis and the CYLD gene: new lessons on the molecular principles of epithelial growth control

AU - Massoumi, Ramin

AU - Paus, Ralf

PY - 2007

Y1 - 2007

N2 - Analysing cylindromatosis and the associated defects in the CYLD gene is providing novel insights into the molecular principles of epithelial growth control and carcinogenesis in, and beyond, the skin. In this review, we summarize the histopathology and histogenesis of cylindromas, and the available genetic information on patients with these skin appendage tumors. Focusing on recent data concerning the normal functions and signaling interactions of the CYLD gene product, we explain how CYLD interferes with TNF-alpha or TLR-mediated signaling as well as with JNK or NF-kappa B-dependent p65/50 signaling to limit inflammation. In addition, we delineate how CYLD interferes with activation of the proto-oncogene BCl3 and with cyclin D1 expression to limit tumorigenesis, and chart how tumor growth-promoting agents or UV light and inflammatory mediators can activate CYLD. We argue that these recent insights into CYLD function and cylindroma pathogenesis may lead to the development of novel molecular strategies for cancer prevention and treatment.

AB - Analysing cylindromatosis and the associated defects in the CYLD gene is providing novel insights into the molecular principles of epithelial growth control and carcinogenesis in, and beyond, the skin. In this review, we summarize the histopathology and histogenesis of cylindromas, and the available genetic information on patients with these skin appendage tumors. Focusing on recent data concerning the normal functions and signaling interactions of the CYLD gene product, we explain how CYLD interferes with TNF-alpha or TLR-mediated signaling as well as with JNK or NF-kappa B-dependent p65/50 signaling to limit inflammation. In addition, we delineate how CYLD interferes with activation of the proto-oncogene BCl3 and with cyclin D1 expression to limit tumorigenesis, and chart how tumor growth-promoting agents or UV light and inflammatory mediators can activate CYLD. We argue that these recent insights into CYLD function and cylindroma pathogenesis may lead to the development of novel molecular strategies for cancer prevention and treatment.

U2 - 10.1002/bies.20677

DO - 10.1002/bies.20677

M3 - Review article

VL - 29

SP - 1203

EP - 1214

JO - BioEssays

JF - BioEssays

SN - 0265-9247

IS - 12

ER -